Rifaximin for Sickle Cell Disease

Authors

Seah H. Lim, New York Medical CollegeFollow
Dibyendu Dutta
Judy Moore

DOI

10.1002/ajh.25637

Journal Title

American Journal of Hematology

First Page

E325

Last Page

E328

Document Type

Letter to the Editor

Publication Date

December 2019

Department

Medicine

Disciplines

Medicine and Health Sciences

Recommended Citation

Lim, S., Dutta, D., & Moore, J. (2019). Rifaximin for Sickle Cell Disease. American Journal of Hematology, 94 (12), E325-E328. https://doi.org/10.1002/ajh.25637